Clinical trial
Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine…
NCT00369109 · Barbara Ann Karmanos Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00369109 |
|---|---|
| Title | Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors |
| Official title | Collection of Skin Biopsy With Hair Follicles as Surrogate to Develop Biomarker Assays From Patients With Advanced Solid Tumor Malignancies Receiving Either Single Agent Weekly Irinotecan or Gemcitabine |
| Lead sponsor | Barbara Ann Karmanos Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer, Colorectal Cancer, Pancreatic Cancer |
| Intervention type | Other, Procedure |
| Interventions | biologic sample preservation procedure, immunohistochemistry staining method, laboratory biomarker analysis, biopsy |
| Enrollment | 60 |
| Start date | Feb 1, 2006 |
| Primary completion | Nov 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Aug 29, 2006 |
| Last update posted | Apr 8, 2013 |
| Countries | United Kingdom, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: